David B Seligson - JoVE Visualize

Showing results (1-10 of 37) with videos related to

Pageof 4

Sort By:

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 22, 2005

The tissue micro-array as a translational research tool for biomarker profiling and validationDavid B Seligson

Journal of Biopharmaceutical Statistics|October 8, 2004

Statistical methods for analyzing tissue microarray dataXueli Liu, Vladimir Minin, Yunda Huang, et al.

Journal of Neuropathology and Experimental Neurology|August 3, 2002

Tissue microarrays in the study of non-neoplastic disease of the nervous systemJared Goldstine, David B Seligson, Pouneh Beizai, et al.

Nature|July 1, 2005

Global histone modification patterns predict risk of prostate cancer recurrenceDavid B Seligson, Steve Horvath, Tao Shi, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2012

Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer developmentPeggy S Sullivan, Erin L Maresh, David B Seligson, et al.

Hormones & Cancer|September 27, 2012

IGFBP-3 nuclear localization predicts human prostate cancer recurrenceDavid B Seligson, Hong Yu, Sheila Tze, et al.

BMC Cancer|June 30, 2010

Elevated MED28 expression predicts poor outcome in women with breast cancerNam K Yoon, Erin L Maresh, Yahya Elshimali, et al.

International Journal of Oncology|January 19, 2008

Expression of arginase II in prostate cancerShannon M Mumenthaler, Hong Yu, Sheila Tze, et al.

European Journal of Cancer (Oxford, England : 1990)|February 26, 2014

Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2αNils Kroeger, David B Seligson, Sabina Signoretti, et al.

Cancer|June 1, 2006

Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcomeMadhuri Wadehra, Sathima Natarajan, David B Seligson, et al.

Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:

Pageof 4

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 22, 2005

The tissue micro-array as a translational research tool for biomarker profiling and validationDavid B Seligson

Journal of Biopharmaceutical Statistics|October 8, 2004

Statistical methods for analyzing tissue microarray dataXueli Liu, Vladimir Minin, Yunda Huang, et al.

Journal of Neuropathology and Experimental Neurology|August 3, 2002

Tissue microarrays in the study of non-neoplastic disease of the nervous systemJared Goldstine, David B Seligson, Pouneh Beizai, et al.

Nature|July 1, 2005

Global histone modification patterns predict risk of prostate cancer recurrenceDavid B Seligson, Steve Horvath, Tao Shi, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2012

Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer developmentPeggy S Sullivan, Erin L Maresh, David B Seligson, et al.

Hormones & Cancer|September 27, 2012

IGFBP-3 nuclear localization predicts human prostate cancer recurrenceDavid B Seligson, Hong Yu, Sheila Tze, et al.

BMC Cancer|June 30, 2010

Elevated MED28 expression predicts poor outcome in women with breast cancerNam K Yoon, Erin L Maresh, Yahya Elshimali, et al.

International Journal of Oncology|January 19, 2008

Expression of arginase II in prostate cancerShannon M Mumenthaler, Hong Yu, Sheila Tze, et al.

European Journal of Cancer (Oxford, England : 1990)|February 26, 2014

Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2αNils Kroeger, David B Seligson, Sabina Signoretti, et al.

Cancer|June 1, 2006

Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcomeMadhuri Wadehra, Sathima Natarajan, David B Seligson, et al.

Pageof 4